Opus Genetics (IRD) Capital Expenditures Growth (1y) (2011 - 2019)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 143.40% |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 537.41% |
| Mar 31, 2019 | 423.06% |
| Sep 30, 2018 | 932.99% |
| Jun 30, 2018 | -93.02% |
| Mar 31, 2018 | -36.44% |
| Dec 31, 2017 | 13,249.63% |
| Sep 30, 2017 | 359.97% |
| Jun 30, 2017 | 378.39% |
| Mar 31, 2017 | -13.73% |
| Dec 31, 2016 | -95.89% |
| Sep 30, 2016 | -98.13% |
| Jun 30, 2016 | -34.54% |
| Mar 31, 2016 | -42.08% |
| Dec 31, 2015 | -11.64% |
| Sep 30, 2015 | 151.64% |
| Jun 30, 2015 | -57.36% |
| Mar 31, 2015 | 110.42% |
| Dec 31, 2014 | 200.68% |
| Sep 30, 2014 | -64.46% |
| Jun 30, 2014 | 944.30% |
| Mar 31, 2014 | 519.21% |
| Dec 31, 2011 | 674.70% |
| Sep 30, 2011 | 202.14% |